IQVIA Holdings Debt to Equity Ratio 2012-2025 | IQV
Current and historical debt to equity ratio values for IQVIA Holdings (IQV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IQVIA Holdings debt/equity for the three months ending September 30, 2025 was 2.03.
| IQVIA Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $22.44B | $6.29B | 3.57 |
| 2025-06-30 | $22.85B | $5.79B | 3.95 |
| 2025-03-31 | $21.34B | $5.99B | 3.57 |
| 2024-12-31 | $20.83B | $6.07B | 3.43 |
| 2024-09-30 | $20.21B | $6.97B | 2.90 |
| 2024-06-30 | $19.68B | $6.71B | 2.93 |
| 2024-03-31 | $20.23B | $6.34B | 3.19 |
| 2023-12-31 | $20.57B | $6.11B | 3.37 |
| 2023-09-30 | $20.17B | $5.81B | 3.48 |
| 2023-06-30 | $20.29B | $5.75B | 3.53 |
| 2023-03-31 | $19.81B | $5.93B | 3.34 |
| 2022-12-31 | $19.57B | $5.77B | 3.40 |
| 2022-09-30 | $18.88B | $5.35B | 3.53 |
| 2022-06-30 | $19.06B | $5.35B | 3.56 |
| 2022-03-31 | $19.05B | $5.92B | 3.22 |
| 2021-12-31 | $18.65B | $6.04B | 3.09 |
| 2021-09-30 | $18.20B | $5.83B | 3.12 |
| 2021-06-30 | $18.18B | $5.76B | 3.16 |
| 2021-03-31 | $18.23B | $6.24B | 2.92 |
| 2020-12-31 | $18.28B | $6.28B | 2.91 |
| 2020-09-30 | $17.73B | $6.11B | 2.90 |
| 2020-06-30 | $17.33B | $5.85B | 2.96 |
| 2020-03-31 | $17.28B | $5.80B | 2.98 |
| 2019-12-31 | $16.99B | $6.26B | 2.71 |
| 2019-09-30 | $16.50B | $6.39B | 2.58 |
| 2019-06-30 | $16.29B | $6.78B | 2.40 |
| 2019-03-31 | $16.24B | $6.87B | 2.37 |
| 2018-12-31 | $15.60B | $6.95B | 2.24 |
| 2018-09-30 | $15.04B | $7.46B | 2.02 |
| 2018-06-30 | $15.01B | $7.61B | 1.97 |
| 2018-03-31 | $14.78B | $8.45B | 1.75 |
| 2017-12-31 | $14.61B | $8.24B | 1.77 |
| 2017-09-30 | $14.94B | $7.51B | 1.99 |
| 2017-06-30 | $14.01B | $7.77B | 1.80 |
| 2017-03-31 | $13.38B | $7.80B | 1.72 |
| 2016-12-31 | $12.35B | $8.86B | 1.39 |
| 2016-09-30 | $4.21B | $-0.08B | -51.40 |
| 2016-06-30 | $4.19B | $-0.23B | -18.33 |
| 2016-03-31 | $4.19B | $-0.21B | -20.34 |
| 2015-12-31 | $4.26B | $-0.34B | -12.69 |
| 2015-09-30 | $4.21B | $-0.18B | -23.42 |
| 2015-06-30 | $4.04B | $-0.70B | -5.76 |
| 2015-03-31 | $3.85B | $-0.61B | -6.29 |
| 2014-12-31 | $4.00B | $-0.70B | -5.68 |
| 2014-09-30 | $3.64B | $-0.54B | -6.79 |
| 2014-06-30 | $3.60B | $-0.62B | -5.79 |
| 2014-03-31 | $3.62B | $-0.56B | -6.47 |
| 2013-12-31 | $3.73B | $-0.67B | -5.60 |
| 2013-09-30 | $3.55B | $-0.71B | -4.99 |
| 2013-06-30 | $3.45B | $-0.80B | -4.32 |
| 2013-03-31 | $3.75B | $-1.32B | -2.84 |
| 2012-12-31 | $3.86B | $-1.36B | -2.84 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2012-03-31 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $3.29B | $-0.97B | -3.40 |
| 2010-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $40.073B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $235.186B | 27.95 |
| Intuitive Surgical (ISRG) | United States | $187.838B | 71.78 |
| IDEXX Laboratories (IDXX) | United States | $55.405B | 55.02 |
| Edwards Lifesciences (EW) | United States | $48.548B | 32.55 |
| Alcon (ALC) | Switzerland | $39.713B | 26.76 |
| Mettler-Toledo (MTD) | United States | $28.729B | 33.61 |
| DexCom (DXCM) | United States | $28.417B | 39.17 |
| STERIS (STE) | Ireland | $25.471B | 26.29 |
| Waters (WAT) | United States | $23.361B | 30.89 |
| Coloplast (CLPBY) | Denmark | $19.201B | 32.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.786B | 0.00 |
| Hologic (HOLX) | United States | $16.729B | 17.58 |
| Penumbra (PEN) | United States | $14.069B | 98.97 |
| Globus Medical (GMED) | United States | $12.383B | 25.99 |
| Masimo (MASI) | United States | $7.598B | 24.35 |
| Glaukos (GKOS) | United States | $6.891B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.232B | 19.80 |
| TransMedics (TMDX) | United States | $4.624B | 54.78 |
| Teleflex (TFX) | United States | $4.570B | 7.28 |
| LivaNova (LIVN) | United Kingdom | $3.449B | 18.63 |
| Veracyte (VCYT) | United States | $3.341B | 38.08 |
| Integer Holdings (ITGR) | United States | $3.021B | 14.18 |
| Elekta AB (EKTAY) | Sweden | $2.486B | 23.26 |
| Alphatec Holdings (ATEC) | United States | $2.320B | 0.00 |
| Artivion (AORT) | United States | $2.038B | 93.52 |
| Nihon Kohden (NHNKY) | Japan | $2.026B | 17.69 |
| UFP Technologies (UFPT) | United States | $1.995B | 26.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.628B | 0.00 |
| AxoGen (AXGN) | United States | $1.514B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.349B | 0.00 |
| IRadimed (IRMD) | United States | $1.283B | 61.13 |
| Pulse Biosciences (PLSE) | United States | $1.023B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.927B | 5.02 |
| Pacific Biosciences Of California (PACB) | United States | $0.779B | 0.00 |
| SiBone (SIBN) | United States | $0.729B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.703B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.647B | 37.64 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.12 |
| Alpha Tau Medical (DRTS) | Israel | $0.593B | 0.00 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 12.60 |
| OrthoPediatrics (KIDS) | United States | $0.454B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.446B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.428B | 0.00 |
| RxSight (RXST) | United States | $0.391B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.372B | 61.94 |
| Sight Sciences (SGHT) | United States | $0.318B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.287B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.266B | 0.00 |
| 908 Devices (MASS) | United States | $0.248B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.140B | 0.00 |
| Solana (HSDT) | United States | $0.140B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.133B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.59 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |